
Trade Deal Takes Away Pharma’s Biologic Exclusivity And Promotes Drug Competition
The trade deal announced yesterday between the United States, Mexico and Canada takes away pharmaceutical companies’ 10-year exclusivity for biologics. In addition, the United States-Mexico-Canada Agreement (USMCA) undos three additional years of patent protection when drug companies submit paperwork about a new use of a drug.